NuVision Biotherapies

NuVision Biotherapies is a regenerative medicine company developing tissue-based biotherapies for ocular surface disease and trauma.

Its proprietary processing technology manufactures dry-preserved human amniotic membrane grafts that retain the membrane's natural barrier and healing properties whilst enabling ambient storage.

Products are sold into NHS ophthalmology and optometry settings, with additional applications in veterinary medicine.